Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sangamo Therapeutics (SGMOQ) Asset Writedowns and Impairment (2015 - 2025)

Updated

Sangamo Therapeutics (SGMOQ) reported Asset Writedowns and Impairment of $13.24 million for Q4 2025.

Analysis

Sangamo Therapeutics (SGMOQ) Asset Writedowns and Impairment (2015 - 2025) Analysis & Trends

Dating back to Q1 2015, Sangamo Therapeutics' Asset Writedowns and Impairment record includes 7 quarters.

  • By year, Asset Writedowns and Impairment came in at $5.52 million in FY2024 (-93.8%) and $89.49 million in FY2023.
  • The Q4 2025 figure ranks as the highest quarterly Asset Writedowns and Impairment since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Sangamo Therapeutics 42.03 Mn -72.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 13.24 Mn
Jun 30, 2024 1.17 Mn
Mar 31, 2024 4.35 Mn
Sep 30, 2023 44.80 Mn
Jun 30, 2023 51.35 Mn
Mar 31, 2023 38.14 Mn
Mar 31, 2015 1.87 Mn
API Access

Sangamo Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY